Money Concepts Capital’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Money Concepts Capital’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-236	Closed	-$5.94K	–	1631
2022 Q4	$5.94K	Sell	236 -4,501	-95%	-$121K	﹤0.01%	2270
2022 Q3	$125K	Sell	4,737 -294	-6%	-$9.07K	0.01%	527
2022 Q2	$149K	Sell	5,031 -740	-13%	-$22.1K	0.01%	475
2022 Q1	$199K	Sell	5,771 -557	-9%	-$19.7K	0.01%	742
2021 Q4	$277K	Buy	+6,328	New	+$300K	0.02%	424

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Money Concepts Capital's IDNA Position: Q1 2023 in Review

Money Concepts Capital sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2023, closing a stake of 236 shares — an estimated $5.94K sold.

Money Concepts Capital first reported a position in IDNA in Q4 2021 and held it in 5 quarters. The position peaked at $277K in Q4 2021. 75 funds tracked by Wall St. Rank hold IDNA as of Q1 2023.

Money Concepts Capital reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2023 after selling out during the quarter.
Money Concepts Capital sold 236 iShares Genomics Immunology and Healthcare ETF shares in Q1 2023, an estimated $5.94K.
Money Concepts Capital first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 5 quarters.
Money Concepts Capital's iShares Genomics Immunology and Healthcare ETF position peaked at $277K in Q4 2021.
75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.